Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001214659-20-005339

Chief Innovation/Tech Officer gave up 4,132 shares (to pay taxes)

  • Chief Innovation/Tech Officer acquired 14,572 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schobel Alexander Mark · Chief Innovation/Tech Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-31 Exercise or conversion : show line 1 in the form +14,572 916,685 D
2020-05-31 Shares withheld for taxes : show line 2 in the form −4,132 $4.87 $20,123 912,553 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-31 Exercise or conversion : show line 3 in the form Restricted Stock Units −14,572 0 D
Loading xslF345X03/marketforms-48951.xml…